InMed Pharmaceuticals Inc.
For the period ended Feb 11, 2026. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 11, 2026 · Filed Feb 12, 2026
Use the contents to explore the available documents and sections.
INM$15.56+17.8%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Next development steps:
Next development steps:
Advancing CMC activities for scale-up and supply
Dose ranging studies in two species
Preparing for a pre-IND meeting with the FDA
GLP-enabling studies to support an IND submission
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.